BFEC
ONC

Benjamin F. Edwards & Company’s BeOne Medicines Ltd ONC Stock Holding History

Benjamin F. Edwards & Company’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$124K Buy
872
+51
+6% +$7.86K ﹤0.01% 1051
2024
Q1 		$128K Buy
821
+279
+51% +$44.9K ﹤0.01% 1031
2023
Q4 		$98K Buy
+542
New +$98.1K ﹤0.01% 1071

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return

Benjamin F. Edwards & Company's ONC Position: Q2 2024 in Review

Benjamin F. Edwards & Company increased its BeOne Medicines Ltd (ONC) stake by 6.2% in Q2 2024, buying an estimated $7.86K and bringing the position to 872 shares worth $124K. The position accounts for ﹤0.01% of the portfolio, ranked #1051.

Benjamin F. Edwards & Company first reported a position in ONC in Q4 2023 and has held it in 3 quarters since. The position peaked at $128K in Q1 2024. 200 funds tracked by Wall St. Rank hold ONC as of Q2 2024.

  • Benjamin F. Edwards & Company held 872 shares of BeOne Medicines Ltd worth $124K as of Q2 2024.
  • Benjamin F. Edwards & Company bought 51 BeOne Medicines Ltd shares in Q2 2024, an estimated $7.86K.
  • BeOne Medicines Ltd made up ﹤0.01% of Benjamin F. Edwards & Company's portfolio in Q2 2024, its #1051 holding.
  • Benjamin F. Edwards & Company first reported a position in BeOne Medicines Ltd in Q4 2023 and has held it in 3 quarters since.
  • Benjamin F. Edwards & Company's BeOne Medicines Ltd position peaked at $128K in Q1 2024.
  • 200 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2024.

Based on Benjamin F. Edwards & Company's 13F filing for Q2 2024, filed 12 Aug 2024.